Ashwani Verma Stock Analyst Profile - UBS Research Coverage - Stocknear

Ashwani Verma

Stock Analyst at UBS

(4.69)
# 1300
Out of 5,459 analysts
88
Total ratings
Success rate
Average return
24 Stocks
Name Action PT Current % Upside Ratings Updated
AVDL Avadel Pharmaceutica...
Maintains: Strong Buy
13 20
14.87 34.5% 3 Aug 21, 2025
UTHR United Therapeutics
Maintains: Strong Buy
385 415
305.16 35.99% 6 Aug 13, 2025
ACAD ACADIA Pharmaceutica...
Maintains: Strong Buy
32 36
26.57 35.49% 5 Aug 8, 2025
EXEL Exelixis
Maintains: Neutral
43 38
38.5 -1.3% 4 Jul 30, 2025
IMVT Immunovant
Maintains: Neutral
17 18
15.18 18.58% 1 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
152 174
138.13 25.97% 9 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 54
34.72 55.53% 3 Jul 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 23
18.05 27.42% 9 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
33 42
29.25 43.59% 5 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
61 61
84.84 -28.1% 1 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
47 41
37.83 8.38% 5 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 48
38.05 26.15% 2 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
1.14 -7.89% 5 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
145 179
124.43 43.86% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
106 114
69.9 63.09% 2 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 54
15.59 246.38% 3 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
83 79
131.87 -40.09% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
107 105
121.86 -13.84% 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28
36.05 -22.33% 3 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 7
90.68 -92.28% 1 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
209
329.83 -36.63% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 12
10.42 15.16% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
0.56 2578.57% 1 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
137 71
116.3 -38.95% 3 Aug 4, 2022